Background: Despite the well-documented economic and psychosocial burden of irritable bowel syndrome (IBS), few studies have focused on the impact of IBS on daily activities. This study aims to quantitate impairment in daily activities among IBS patients and to evaluate the relationship between impairment, IBS, quality of life, and psychiatric symptoms.
Individuals with IBS often report high rates of psychopathology and low quality of life. 2, 3 They also tend to miss more days of work, report decreased productivity at work, and use many healthcare resources.
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Despite the well-documented impact of IBS on quality of life, healthcare utilization, and work productivity, relatively few studies have evaluated the impact of IBS on overall daily functioning. With approximately 40-60% of individuals with IBS meeting criteria for a psychiatric disorder 2 and with IBS accounting for 1.5-2.7 million physician visits a year 4 (2-3 times more visits than the general population), it would make sense that individuals with IBS might experience increased difficulty engaging in daily activities and responsibilities.
Existing data on the impact of IBS on daily activities come primarily from large survey studies that have included 1-2 questions about overall daily functioning and quality of life. The results of these studies suggest that individuals with IBS report higher levels of difficulty in a broad range of daily activities when compared to healthy controls 7 ;
that IBS negatively affects both mental and physical functioning (as measured by quality of life questionnaires) 8 ; and that the reported impact of IBS on daily living is almost as high as that of the flu (6.2/10 for IBS compared to 7/10 for the flu). 9 Neurogastroenterol Motil. 2017;29:e12982. wileyonlinelibrary.com/journal/nmo Although there are many published studies that thoroughly evaluate the impact of IBS on quality of life (a measure of perceived emotional, social, and physical problems), only one study to our knowledge has sought to systematically quantitate and characterize impairment of daily activities in a sample of individuals with IBS. 10 In Corney and
Stanton's study, 42 patients completed questionnaires measuring IBS symptom severity and avoidance of daily activities. Avoidance was measured using an 8- 
| MATERIALS AND METHODS

| Sample
This study was approved by an institutional review board in accordance with the provisions of the World Medical Association Declaration of Helsinki. Data were collected from 227 male and female participants with IBS ages 18-70. These participants were recruited as part of an online survey that was advertised on various IBS websites and weblogs. Data were collected using Adobe FormsCentral, an online data collection tool (www.acrobat.com/FormsCentral).
Participation in this survey was anonymous and respondents did not provide any identifying information. Diagnosis of IBS was confirmed through inclusion of the ROME-III questionnaire. Respondents were excluded from the final sample if they: (i) Did not meet criteria for IBS; (ii) Were currently pregnant or had given birth in the last 12 weeks; or (iii) Were diagnosed with crohn's disease or ulcerative colitis.
| Functional impairment assessment
For the purposes of this study, functional impairment (our primary outcome variable) was operationalized as the behavioral outcome of being unable or unwilling to participate in daily activities due to IBS symptoms or fear of IBS symptoms.
As there is no available validated measure of impairment in daily functioning for patients with chronic conditions such as IBS, functional impairment was evaluated using a questionnaire adapted from
Corney and Stanton's original study. 10 The questionnaire evaluated Each domain had two questions: (i) from 0-10 rate your level of avoidance or inability to complete tasks in this domain in the past 2 weeks;
and (ii) was this related to IBS symptoms (yes/no)? See Appendix S1.
| IBS symptom assessment
Participants completed the ROME-III diagnostic questionnaire to confirm IBS diagnosis. 11, 12 The ROME-III criteria are symptom-based and consist of 10 items. Diagnostic sensitivity is 87.8% when compared to clinician diagnosis, and test-retest agreement is 81.7%. 13 In addition, participants completed the IBS Symptom Severity Scale (IBS-SSS)
to measure severity and frequency of IBS symptoms.
14 The IBS-SSS is 5-item scale and each item is measured on a 100 point scale with the total score for ranging from 0 to 500.
| Psychological symptom assessment
Standardized questionnaires from the patient health questionnaire (PHQ) modules (described below) were used to evaluate likely diagnoses of depression, anxiety, and panic. Depression was measured using 
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Panic symptoms were measured using the PHQ-panic module. This measure includes 15 items rated "yes" or "no" over the past 4 weeks. If
Key Points
• The impact of IBS on daily functioning has not been adequately researched. This study characterizes daily impairment in patients with IBS.
• The majority of respondents reported impairment in at least five domains of daily living. Rates of impairment were highest among participants who met questionnairebased criteria for psychiatric diagnoses.
• These results support the importance of integrated psychosocial and medical care for IBS and may support early evaluation and intervention among those with psychiatric diagnoses.
a patient endorses all of the first four items and endorses ≥4 somatic symptoms during an anxiety attack, a diagnosis of panic disorder is probable. 18, 19 Sensitivity and specificity of this algorithm have been found to be 0.75 and 0.96, respectively.
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| Symptom-specific anxiety assessment
Symptom-specific anxiety was measured using the Visceral Sensitivity Index (VSI). 21 The VSI consists of 15 items with a 6-point Likert scale from 0 (strongly disagree) to 5 (strongly agree). The maximum score is 75 (severe gastrointestinal specific anxiety [GSA] ) and a score of 0 indicates no GSA. The VSI demonstrates good reliability (Cronbach's α = 0.93) and good content, convergent, divergent, and predictive validity in IBS patients.
| Quality of life assessment
The SF-12 is a quality of life measure used to assess mental and physical functioning over the past 4 weeks. 
| Statistical methods
Data were stored and analyzed using SPSS v.21 (IBM-SPSS, Chicago IL, USA). Demographic and psychiatric data were summarized using descriptive and frequency analyses. Functional impairment was calculated in two ways: Firstly, reported impairment due to IBS was calculated as a binary variable (yes/no) and then as a continuous variable (average impairment on a 0-10 scale) for each domain.
Functional impairment was reported as percentage of the sample who avoided each domain of daily living and the average rate of impairment for each category. Finally, two composite functional impairment scores were calculated for each participant: (i) the "total rate of impairment," calculated by averaging all reported impairment due to IBS across all categories (range = 0-10) and (ii) the "total number of domains avoided due to IBS" calculated by adding all of the domains with a rating of 1 or higher and identified as avoided or impaired as a result of IBS (range = 0-10).
In our secondary analyses, t tests were used to evaluate differences between participants who met criteria for a psychiatric diagnosis (based on the PHQ modules) and those who did not meet criteria.
| RESULTS
| Demographics and clinical characteristics
A total of 227 respondents completed the online questionnaire. Of these, 179 met eligibility criteria for this study. Mean age in the sample of eligible respondents was 35.54 years old (SD = 13.34 years, range Psychiatric diagnoses were determined using questionnaire-based criteria (PHQ modules).
was later divided into two groups (presence/absence of psychiatric diagnosis).
| Impairment of daily activities
| Characterizing impairment in the entire sample
Functional impairment in the entire sample (n=179) is shown in Fig. 1 . The average rate of impairment due to IBS (as measured on a 0-10 scale) in this sample was 5.33 (range 0-10, SD = 2.15), and the average number of domains impaired due to IBS was 6.39 domains (range 0-10, SD = 2.68). The majority (76.5%) of respondents reported IBS-related impairment in five or more domains of daily living.
| Characterizing impairment by psychiatric diagnosis
Functional impairment by psychiatric diagnosis (as determined by In addition, a higher percentage of participants who met criteria for a psychiatric diagnosis reported impairment in each domain of daily living when compared to participants who did not meet such criteria (Fig. 3) . On average, participants who met criteria for a psychiatric diagnosis reported impairment in 6.90 domains of daily living (SD = 2.53), which was higher than those participants who did not meet criteria (mean = 5.38, SD = 2.62); t(164) = −3.76, P=.000. Participants who met criteria for a psychiatric diagnosis also reported higher rates of impairment in all domains of daily living except for dissatisfaction with appearance and eating alone (Fig. 4) .
| Relationships among variables
The overall rate of functional impairment was significantly correlated with all measured psychosocial and symptom-related variables except for the Mental Component Subscale of the SF-12 (see Table 2 ).
When the sample was divided into those who did and did not meet questionnaire-based criteria for a psychiatric comorbidity, functional impairment remained significantly correlated with the VSI, IBS-SSS, and SF-12 PCS, regardless of presence/absence of psychiatric diagnoses.
However, there were statistically significant differences between respondents who did and did not meet criteria for psychiatric diagnoses .
Respondents with psychiatric comorbidities scored significantly higher on the IBS-SSS (t (164) 
| DISCUSSION
In this study, we observed a high level of impairment and/or avoidance of daily activities associated with IBS. In addition, we found that the level of impairment was higher for subjects who met criteria for depression, anxiety, and/or panic disorder.
The majority of respondents in this study reported IBS-related impairment in daily living, with 76% of the sample reporting some degree of impairment in at least five different domains of daily life. Reported impairment was closely associated with symptom severity, GI-specific anxiety, and quality of life. To our knowledge, this is the first study since Corney and Stanton's original study in 1990 10 to characterize and quantitate the specific impact of IBS on daily functioning. This study contributes uniquely to the large body of research on the effect of IBS on overall quality of life by elucidating the specific behavioral F I G U R E 1 Percent reporting impairment due to IBS and average rates of impairment due to IBS in entire sample (with standard deviations) 25, 26 Although reasons for such low QoL in IBS have not been clearly identified, it is apparent that the impact of IBS on a patient's daily life should not be underestimated.
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Of 10 domains of daily living assessed in this study, social functioning, eating alone, and job functioning were reported to be the most affected by IBS. IBS-related impairments in social functioning and job functioning have been well-demonstrated in other quality of life research. 5 The impact of IBS on eating behavior (i.e., food choices), however, has not yet been well-researched. 28 The findings of this study suggest that individuals with IBS report more impairment when eating alone compared to when eating in groups. This finding is somewhat surprising, as eating in groups typically involves socializing and eating outside of the home, both of which could be potential stressors for an IBS patient. This finding may indicate that individuals with IBS are more likely to regulate or restrict their diets when they are eating alone. Accordingly, the "eating alone" category likely reflects food choices and dietary restrictions, while the "eating in groups" category reflects social eating situations. Moving forward, it may be best to change the title of these domains.
Interestingly, individuals who met questionnaire-based criteria for comorbid depression, anxiety, and/or panic disorder reported a higher degree of impairment/avoidance due to their IBS symptoms when compared to respondents without these psychiatric comorbidities. This is likely due in part to the nature of these diagnoses, all of which are characterized by some degree of impairment in functioning. However, our finding is striking in that the respondents attributed pregnancy. Other GI and non-GI comorbidities were not assessed, which reflects a limitation of this study's sampling. However, given the high diagnostic sensitivity of the ROME-III criteria 13 and the knowledge that a large portion of people suffering from IBS in the general population do not seek medical treatment for their symptoms, 29 this study sample was likely representative of the IBS population.
Secondly, we were inadequately powered to assess differences in daily functioning among IBS subtypes. Prevalence studies in western countries have revealed mixed results regarding prevalence rates of IBS-C and IBS-D, and rates of IBS subtypes appear to vary widely across cultures. 30 Although there are no documented differences in quality of life between IBS-C and IBS-D, it appears that individuals with IBS-D are more likely to be referred to tertiary care clinics, and therefore may be more likely to seek medical attention or to connect with online resources. 31, 32 In our sample, the majority of respondents reported IBS Mixed Type (58.7%), followed by IBS-D (31.8%), and IBS-C (9.5%). Thus, we were unable to draw conclusions about differences in IBS subtypes and our results may be most applicable to nonconstipated IBS patients. 
| CONCLUSION
This study contributes to existing literature by quantitating the level of symptom-related impairment in a sample of participants with ROME-III IBS and by identifying particularly salient psychological and symptom-specific variables that might contribute to such impairment.
